THORP CLAY purchased 9.3% of their position (15K shares) of CLEARSIDE BIOMEDICAL, INC. on the open market
Open‑market purchase worth $13.8K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/24/2025ACC: 0001415889-25-005325
Director10% Owner
Since Dec 2018
+15K
Net shares
Net buyer
$13.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
15K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+15K
Price / share
$0.92
Trade value
$13.80K
% of position
9.3%
2/24/2025
161.14K→176.14K
Total
Net shares
+15K
Net value
$13.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2025 | P · Purchase | +15K | $0.92 | $13.80K | 9.3% | 161.14K | 176.14K |
| Total | +15K | $13.80K | ||||||
Derivative Transactions0
No derivative transactions reported